BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 752866)

  • 1. Patterns of recurrence after regional BCG immunotherapy of bronchial cancer.
    McKneally MF; Maver C; Kellar S; Lininger L
    Recent Results Cancer Res; 1978; 68():286-91. PubMed ID: 752866
    [No Abstract]   [Full Text] [Related]  

  • 2. Attempt at immunotherapy with living BCG in patients with bronchus carcinoma.
    Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G
    Recent Results Cancer Res; 1978; 68():260-7. PubMed ID: 752864
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
    Jansen HM; The TH; de Gast GC; Esselink MT; van der Wal AM; Orie NG
    Thorax; 1978 Aug; 33(4):429-38. PubMed ID: 358479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunotherapy with BCG and mycobacterial fractions and its use in bronchogenic carcinoma (author's transl)].
    Brehmer W; Huckauf H; Ribi E
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():358-65. PubMed ID: 461310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is immunotherapy useful in bronchial carcinoma?].
    Geraint JD
    Schweiz Med Wochenschr; 1977 Apr; 107(13):421-2. PubMed ID: 300502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant therapy of bronchial carcinoma with special attention to immunotherapy].
    Drings P
    Aktuelle Probl Chir Orthop; 1982; 22():30-5. PubMed ID: 6121510
    [No Abstract]   [Full Text] [Related]  

  • 7. [5 years of nonspecific active immunotherapy with a transformed mycobacterium in operated primary bronchial cancers. Study of postoperative survival of from 1 to 3 years].
    Djurovic V; Decroix G
    Ann Med Interne (Paris); 1978 Apr; 129(4):237-42. PubMed ID: 666198
    [No Abstract]   [Full Text] [Related]  

  • 8. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
    Pouillart P; Mathé G; Palangie T; Schwarzenberg L; Huguenin P; Morin P; Gautier H; Baron A
    Recent Results Cancer Res; 1977; (62):151-5. PubMed ID: 341247
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunotherapy of malignant diseases. A way towards the goal?].
    Riethmüller G
    MMW Munch Med Wochenschr; 1978 Feb; 120(6):161-2. PubMed ID: 305530
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilot study on the effect of BCG vaccination in patients with bronchial carcinoma.
    Nilsson BS; Afeldt PE
    Scand J Respir Dis; 1975 Aug; 56(2):84-6. PubMed ID: 1172630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of PPD test in patients with bronchial carcinoma treated by BCG vaccine (author's transl)].
    Jakasa D
    Plucne Bolesti Tuberk; 1977; 29(3-4):265-8. PubMed ID: 609635
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
    Jansen HM; The TH; Orie NG
    Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunorestoration in epidermoid cancer of the bronchi. Therapeutic results (proceedings)].
    Pouillart P; Palangie T; Jouve M; Huguenin P; Gautier H; Morin P; Baron A
    J Radiol Electrol Med Nucl; 1978 Nov; 59(11):654-7. PubMed ID: 748546
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of bronchial cancer with a water-saline extract of BCG].
    Khadzhiev S; Kavaklieva-Dimitrova Ia
    Vopr Onkol; 1971; 17(8):51-7. PubMed ID: 4943964
    [No Abstract]   [Full Text] [Related]  

  • 15. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
    Korovin AI; Savvin VT
    Urol Nefrol (Mosk); 1996; (1):19-21. PubMed ID: 8659034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG prophylaxis in bladder cancer produces activation of recruited neutrophils.
    Vita F; Siracusano S; Abbate R; Ciciliato S; Borelli V; Soranzo MR; Zabucchi G
    Can J Urol; 2011 Feb; 18(1):5517-23. PubMed ID: 21333042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V; Knopf B
    Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mumps virus and BCG vaccine in metastatic melanoma.
    Minton JP
    Arch Surg; 1973 Apr; 106(4):503-6. PubMed ID: 4572347
    [No Abstract]   [Full Text] [Related]  

  • 19. Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma.
    Law MR; Lam WK; Studdy PR; Pugsley WB; Hodson ME
    Br J Dis Chest; 1982 Apr; 76(2):151-6. PubMed ID: 7093133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
    Morton DL; Eilber FR; Holmes EC; Hunt JS; Ketcham AS; Silverstein MJ; Sparks FC
    Ann Surg; 1974 Oct; 180(4):635-43. PubMed ID: 4412271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.